Primary Site >> Liver Cancer
Gene >> IL2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Treatment for unresectable hepatoma via selective hepatic arterial infusion of lymphokine-activated killer cells generated from autologous spleen cells. PMID: 2425926 Ref: Induction of lymphokine-activated killer cells in strain 2 guinea pigs with human interleukin-2. PMID: 3489527 |
Ref: Interleukin 2 and lymphokine-activated killer cells in the treatment of childhood primary hepatocellular carcinoma--a preliminary report. PMID: 3040030 |
Ref: Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer. PMID: 2460239 Ref: Immunotherapy of hepatocellular carcinoma with autologous lymphokine-activated killer cells and/or recombinant interleukin-2. PMID: 2838488 Ref: Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity. PMID: 3257715 |
Ref: Adoptive immunotherapy administered via the hepatic artery and intralesional interleukin-2 in hepatocellular carcinoma. PMID: 2475251 Ref: Defective function of lymphokine-activated killer cells and natural killer cells in patients with hepatocellular carcinoma. PMID: 2537790 Ref: Circulating LAK-1 cells and autologous mixed lymphocyte reaction in patients with hepatocellular carcinoma. PMID: 2539011 Ref: Intratumoral echo-guided injection of interleukin-2 and lymphokine-activated killer cells in hepatocellular carcinoma. PMID: 2559885 Ref: Unimpaired ability to generate adherent lymphokine-activated killer (A-LAK) cells in patients with primary or metastatic liver tumors. PMID: 2624925 Ref: [Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect]. PMID: 2786379 Ref: Lymphokine-activated killer cell activity in patients with primary and metastatic malignant liver tumors. PMID: 2787271 Ref: Lymphokine-activated killer cell induction in tumor-infiltrating leukocytes from colon cancer patients. PMID: 2804913 |
Ref: Defective immunological functions associated with abnormal lymphokine-activated killer activity in patients with hepatocellular carcinoma. PMID: 1966592 Ref: Functional and phenotypic characteristics of recombinant interleukin-2 or T-cell growth factor-activated splenic lymphoid cells from patients with gastric or hepatocellular carcinoma. PMID: 2167147 Ref: Antitumour effect of intratumoral injection of human recombinant interleukin-2 in patients with hepatocellular carcinoma: a preliminary report. PMID: 2177345 |
Ref: [Significance of reduction surgery for stage IV hepatocellular carcinoma (HCC) and postoperative immunochemotherapy for extension of survival period]. PMID: 1658592 Ref: Crescentic IgA glomerulonephritis following interleukin-2 therapy for hepatocellular carcinoma of the liver. PMID: 1668057 Ref: Effective immunotherapy with local low doses of interleukin-2. PMID: 1810439 Ref: Augmentation of antitumor effect on syngeneic murine solid tumors by an interleukin 2 slow delivery system, the IL-2 mini-pellet. PMID: 1854589 Ref: [Treatment of advanced liver cancer by autologous and/or homologous LAK cells combined with human natural LL-2]. PMID: 1879294 Ref: [LAK cell adoptive immunotherapy and its problems]. PMID: 1944194 |
Ref: Induction of allogeneic tumour- and lymphokine-activated lymphocytes against hepatocellular carcinoma. PMID: 1315167 |
Ref: Cancer immunotherapy with low-dose interleukin-2 subcutaneous administration: potential efficacy in most solid tumor histotypes by a concomitant treatment with the pineal hormone melatonin. PMID: 8023699 Ref: Postoperative chemoimmunotherapy for the treatment of liver cancer. PMID: 8210915 Ref: Immunological responses against an autologous human hepatocellular carcinoma cell line. PMID: 8280838 Ref: Short-duration in vitro interleukin-2-activated mononuclear cells for advanced cancer. A Hong Kong biotherapy pilot study trial. PMID: 8387882 Ref: Interleukin-2 in cancer treatment: disappointing or (still) promising? A review. PMID: 8439974 |
Ref: [Induction of anti-cancer cells and systemic immune response in hepatocellular carcinoma by OK-432]. PMID: 7944416 Ref: Induction by OK-432 of lymphokine activated killer precursor cells in hepatocellular carcinoma. PMID: 7959572 Ref: Immunotherapy of liver metastases of human gastric carcinoma with interleukin 2-activated natural killer cells. PMID: 8033100 |
Ref: Interleukin-2-secreting mouse fibroblasts transfected with genomic DNA from murine neoplasms induce tumor-specific immune responses that prolong the lives of tumor-bearing mice. PMID: 8528961 Ref: Efficacy and tolerability of cancer neuroimmunotherapy with subcutaneous low-dose interleukin-2 and the pineal hormone melatonin - a progress report of 200 patients with advanced solid neoplasms. PMID: 21597854 |
Ref: Intralesional sonographically guided injections of lymphokine-activated killer cells and recombinant interleukin-2 for the treatment of liver tumors: a pilot study. PMID: 9087388 Ref: The tumor-bearing state induces augmented responses of organ-associated lymphocytes to high-dose interleukin-2 therapy in mice. PMID: 9390196 Ref: In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2. PMID: 9449371 Ref: Cytolytic activity of peripheral blood blast cells from patients with acute myeloid leukemia. PMID: 9477127 Ref: Patterns of hepatic and splenic colonization by an attenuated strain of Salmonella typhimurium containing the gene for human interleukin-2: a novel anti-tumor agent. PMID: 10851445 |
Ref: [Clinical evaluation of intermittent hepatic arterial infusion therapy for metastatic liver tumor of gastric and colorectal cancer]. PMID: 9703838 Ref: [Retroviral-mediated transcriptional regulatory elements of alpha-fetoprotein gene directed specific expression of interleukin-2 in murine hepatoma]. PMID: 11717988 |
Ref: Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer. PMID: 11591892 |
Ref: Effects of cryopreservation and phenylacetate on biological characters of adherent LAK cells from patients with hepatocellular carcinoma. PMID: 11925598 Ref: [Changes of immune function in liver cirrhosis patients after splenectomy combined with resection of hepatocellular carcinoma]. PMID: 11955389 Ref: Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo. PMID: 12046071 Ref: Locoregional immunochemotherapy in hepatocellular carcinoma. PMID: 12143214 Ref: [Immunoprotective effect of IL-2 and B7-1 gene co-transfected liver cancer vaccines on hepatocarcinogenesis in mice]. PMID: 12502440 |
Ref: Prevention of hepatocellular carcinoma in mice by IL-2 and B7-1 genes co-transfected liver cancer cell vaccines. PMID: 14562374 Ref: Effects of splenectomy in patients with cirrhosis undergoing hepatic resection for hepatocellular carcinoma. PMID: 14606076 |
Ref: Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. PMID: 16344072 |
Ref: Treatment of antibody-mediated rejection with high-dose immunoglobulins in ABO-incompatible liver transplant recipient. PMID: 17263788 |
Ref: Generation of cellular immune responses to HCV NS5 protein through in vivo activation of dendritic cells. PMID: 20002303 |
Ref: A new membrane re-anchored protein originating from GPC3 against hepatoma cells HepG2. PMID: 21904776 |
Ref: Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma. PMID: 23223899 |
Ref: T cells redirected to interleukin-13Ralpha2 with interleukin-13 mutein--chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Ralpha1. PMID: 24841514 Ref: Kanglaite stimulates anticancer immune responses and inhibits HepG2 cell transplantationinduced tumor growth. PMID: 25119060 |
Ref: Identification and functional characterization of a novel fungal immunomodulatory protein from Postia placenta. PMID: 25662032 Ref: Characterization of solid tumors induced by polycyclic aromatic hydrocarbons in mice. PMID: 25913077 |
Ref: Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma. PMID: 27197065 Ref: Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor Effect. PMID: 27736965 |
Ref: Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting. PMID: 27965307 Ref: Tumor-Derived alpha-Fetoprotein Directly Drives Human Natural Killer-Cell Activation and Subsequent Cell Death. PMID: 28468916 Ref: CpG oligonucleotides increase HBV-specific cytokine responses in whole blood and enhance cytokine release assay sensitivity. PMID: 28739303 |
Ref: Genetically engineered recombinant adenovirus expressing interleukin2 for hepatocellular carcinoma therapy. PMID: 29115604 |